Live from the NIH registry
Studies recruiting near Gulfport right now
Top 25 of 37 recruiting studies, sorted by proximity — each links to its official registry page
STRIVE Post-Market Registry Study
Emphysema
N/A
Observational 150 participants sought
Memorial Hospital at Gulfport — Gulfport, Mississippi (4.4 mi)
· Sponsor: Olympus Corporation of the Americas
Evaluation of Pulsed Field Ablation of the Posterior Nasal Nerve for Chronic Rhinitis
Chronic Rhinitis
N/A
Interventional 30 participants sought
Bay Area ENT — Ocean Springs, Mississippi (14.5 mi)
· Sponsor: Aventix Medical Inc.
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
RSV Infection
Phase 3
Interventional 550 participants sought
Velocity Clinical Research, Gulfport — Gulfport, Mississippi (4.4 mi)
· Sponsor: Pfizer
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Acute Migraine
Phase 3
Interventional 1,000 participants sought
DelRicht Research — Gulfport, Mississippi (4.4 mi)
· Sponsor: Kallyope Inc.
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Obesity, Overweight
Phase 3
Interventional 125 participants sought
Dynamed Clinical Research, LP d/b/a DM Clinical Research — Gulfport, Mississippi (4.4 mi)
· Sponsor: Eli Lilly and Company
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
COPD (Chronic Obstructive Pulmonary Disease)
Phase 3
Interventional 5,000 participants sought
Research Site — Gulfport, Mississippi (4.4 mi)
· Sponsor: AstraZeneca
A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities
Obesity, Overweight
Phase 3
Interventional 150 participants sought
MedPharmics, LLC — Gulfport, Mississippi (4.4 mi)
· Sponsor: Eli Lilly and Company
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Obesity, Overweight
Phase 3
Interventional 1,100 participants sought
ACCOMPLISH-2 Research Site — Gulfport, Mississippi (4.4 mi)
· Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 3
Interventional 734 participants sought
Velocity Clinical Research - Gulfport — Gulfport, Mississippi (4.4 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Obesity, Overweight
Phase 3
Interventional 3,003 participants sought
AURORA-1 Clinical Site — Gulfport, Mississippi (4.4 mi)
· Sponsor: Ascletis Pharma (China) Co., Limited
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stage I Breast Cancer
Phase 3
Interventional 1,670 participants sought
Gulfport Memorial Hospital — Gulfport, Mississippi (4.4 mi)
· Sponsor: NRG Oncology
A Study of GEn-1124 in Subjects With Acute Respiratory Distress Syndrome (ARDS)
Respiratory Distress Syndrome, Acute
Phase 2
Interventional 52 participants sought
Ocean Springs Hospital — Ocean Springs, Mississippi (14.5 mi)
· Sponsor: GEn1E Lifesciences
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Graves' Disease
Phase 2
Interventional 240 participants sought
Site Number - 1068 — Gulfport, Mississippi (4.4 mi)
· Sponsor: Immunovant Sciences GmbH
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Diabetes Mellitus, Type 2, Hypertension
Phase 3
Interventional 11,800 participants sought
Memorial Hospital Gulfport — Gulfport, Mississippi (4.4 mi)
· Sponsor: Boehringer Ingelheim
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Obesity, Overweight
Phase 3
Interventional 3,600 participants sought
ACCOMPLISH-1 Research Site — Gulfport, Mississippi (4.4 mi)
· Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Chronic Idiopathic Constipation (CIC)
Phase 3
Interventional 692 participants sought
DelRicht Clinical Research - Gulfport — Gulfport, Mississippi (4.4 mi)
· Sponsor: Ardelyx
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Progressive Pulmonary Fibrosis, Interstitial Lung Disease
Phase 3
Interventional 698 participants sought
Memorial Hospital at Gulfport — Gulfport, Mississippi (4.4 mi)
· Sponsor: United Therapeutics
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
Lung Cancer Diagnosis
N/A
Observational 20,000 participants sought
Memorial Hospital at Gulfport — Gulfport, Mississippi (4.4 mi)
· Sponsor: Freenome Holdings Inc.
Evaluating the Efficacy of NeoThelium FT in the Treatment of Chronic Open Wounds
Open Wound
N/A
Interventional 132 participants sought
MedCentris of D'iberville — D'Iberville, Mississippi (10.7 mi)
· Sponsor: NuScience Medical Biologics, LLC
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Lumbar Spinal Stenosis
N/A
Observational 8,000 participants sought
Singing River Gulfport — Gulfport, Mississippi (4.4 mi)
· Sponsor: Stryker Instruments
Patient Retrospective Outcomes (PRO)
Chronic Pain
N/A
Observational 15,000 participants sought
NeuroSpecs-Gulfport Performance Spine — Gulfport, Mississippi (4.4 mi)
· Sponsor: Boston Scientific Corporation
Mobile Health for Adherence in Breast Cancer Patients
Anatomic Stage IV Breast Cancer AJCC v8, Breast Carcinoma
N/A
Interventional 410 participants sought
Gulfport Memorial Hospital — Gulfport, Mississippi (4.4 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Tissue Repair Gel in Venous Leg Ulcers (US)
Venous Leg Ulcer, Venous Ulcer
Phase 3
Interventional 312 participants sought
Clincial Research Site 07 — D'Iberville, Mississippi (10.7 mi)
· Sponsor: TR Therapeutics
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
Migraine
Phase 3
Interventional 1,800 participants sought
DelRicht Research — Gulfport, Mississippi (4.4 mi)
· Sponsor: Kallyope Inc.
A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)
Cataract
Phase 3
Interventional 528 participants sought
Tekwani Vision Center — Bay Saint Louis, Mississippi (17.5 mi)
· Sponsor: Melt Pharmaceuticals